|
|
Article: Webcast Alert: Isis Pharmaceuticals and Genzyme Corporation to Present Mipomersen Phase 3 Data in HoFH During AHA.
- Article from:
- PR Newswire
- Article date:
- November 11, 2009
CopyrightCOPYRIGHT 2009 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
CARLSBAD, Calif., Nov. 11 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc. and Genzyme Corporation announce the following webcast:
What: Isis Pharmaceuticals and Genzyme Corporation to present
mipomersen Phase 3 data in HoFH during the American Heart
Association's 2009 Scientific Sessions in Orlando, FL
When: Tuesday, November 17, 2009, at 9:00 a.m. PT / 12:00 p.m. ET
Where: http://www.isispharm.com/ or http://www.genzyme.com/
How: Live on the Internet. Simply log on to one of our Web sites
listed above.
Isis Contacts: Kristina Lemonidis (Investors)
...